Casdin Capital is an investment firm focused on the life sciences and healthcare sectors, including biotechnology, medical technology, and related companies. It serves institutional and other sophisticated investors through investment strategies targeting growth and innovation in healthcare.
Subscribe to see Casdin Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Casdin Capital is an asset management company headquartered in United States. Xcout tracks 10 named people at Casdin Capital, including Alexandria Fisk (Chief Operating Officer).
4 more named people on record for Casdin Capital, with roles, board committees and tenure — see the full roster →
A few of Casdin Capital's closest competitors — see the full list of competitors and alternatives →
Forbion is a European venture capital firm focused on life sciences, including biotechnology and medical technology. It manages investment funds and provides capital to innovative healthcare companies, primarily serving entrepreneurs and investors in the European life sciences sector.
Monograph Capital is a life-sciences investment firm that provides venture capital to companies developing innovative therapeutics and related healthcare technologies. It works with entrepreneurs and management teams building businesses in the biotechnology and healthcare sectors.
Schonfeld Strategic Advisors is a global investment firm that manages capital through multiple quantitative, fundamental, and discretionary trading strategies. It serves institutional and other qualified investors through hedge funds and related investment vehicles.
HBM Partners is a Swiss healthcare asset manager and investor that provides venture, growth, and buy-out financing to private and public companies in the biopharma, medtech, diagnostics, and healthcare sectors. The firm advises specialized equity investment funds and supports entrepreneurial companies by providing capital and strategic industry expertise.
KDventures is a listed investment company that invests in innovative pharmaceutical, biotech, and medical technology companies. Through active ownership and specialized life science expertise, the company supports its portfolio businesses in developing treatments for severe diseases.
RTW Venture Fund Limited primarily focuses on sourcing groundbreaking innovations poised for substantial growth within the biotechnology, pharmaceutical, and medical technology fields. The fund allocates capital to enterprises that are engineering advanced therapies and cutting-edge technologies, ultimately aiming to profoundly enhance patient quality of life.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Casdin Capital? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.